Astrana Health, Inc. (ASTH) vs Generate Biomedicines, Inc. (GENB)

A side-by-side comparison of Astrana Health, Inc. and Generate Biomedicines, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Astrana Health, Inc. logo
ASTH
Astrana Health, Inc.
$1.84B
$37.20HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Generate Biomedicines, Inc. logo
GENB
Generate Biomedicines, Inc.
$1.79B
$14.00HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT

Total return — ASTH vs GENB

growth of $100 · dividends reinvested · last 1y
ASTH +91.5% (+91.5%/yr)GENB +10.0% (+10.0%/yr)ASTH compounded faster over this window
100150200250Start $100$192$110
ASTH GENB

ASTH vs GENB: by the numbers

  • •ASTH is the larger company ($1.84B vs $1.79B market cap).
  • •ASTH is profitable (1.05% net margin) while GENB runs a net loss (-636.99%).

Metrics side by side

Valuation

MetricASTHGENB
P/E ratio45.50N/A
Forward P/E26.61N/A
P/S ratio0.48N/A
P/B ratio2.223.93
EV / EBITDA13.54N/A
FCF yield8.59%N/A

Profitability

MetricASTHGENB
Gross margin9.22%100.00%
Operating margin2.61%-737.04%
Net margin1.05%-636.99%
ROE4.88%N/A
ROIC4.13%-94.79%

Growth (annualized)

MetricASTHGENB
Revenue CAGR (5Y)53.77%N/A
EPS CAGR (5Y)-15.06%N/A
FCF CAGR (5Y)18.35%N/A
Total return CAGR (5Y)-16.52%N/A

Frequently asked

Is ASTH or GENB more profitable?
ASTH runs the higher net margin — ASTH at 1.05% versus GENB at -636.99%.

Go deeper

Full ASTH analysisFull GENB analysisInteractive comparison tool

Dig into the metrics

Astrana Health P/E ratioAstrana Health ROEGenerate Biomedicines ROEAstrana Health operating marginGenerate Biomedicines operating marginAstrana Health revenue growthGenerate Biomedicines revenue growthAstrana Health free cash flowGenerate Biomedicines free cash flow

Astrana Health & Generate Biomedicines appear in these rankings

Fastest Revenue Growth StocksHighest FCF Yield StocksHighest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.